HOME > TOP STORIES
TOP STORIES
-
BUSINESS Sumitomo Dainippon Carves Out Pain Program, 2025 Launch Eyed for Rare Pediatric Disease
March 29, 2019
-
REGULATORY Opdivo Up for Yet Another Re-Pricing after CEA Confirmatory Analysis, but New Price Undisclosed
March 28, 2019
-
REGULATORY National Cancer Center’s Fujiwara Named New PMDA Chief
March 27, 2019
-
BUSINESS Kymriah OK’ed, Novartis Says It’s Not Up for Outcome-Based Pricing in Japan
March 27, 2019
-
BUSINESS Novartis Snags Japan Approval for CAR-T Therapy Kymriah
March 26, 2019
-
REGULATORY Nesp Biosame Likely to Be Priced at 70% of Originator as Stopgap Measure
March 26, 2019
-
INTERVIEW With HIV Back in Hand, Gilead Heading into Second Phase in Japan Market: Pres. Hermans
March 26, 2019
-
REGULATORY PMDA Chief Kondo to Step Down after 11 Years in Charge
March 25, 2019
-
REGULATORY LDP Lawmakers Not So Positive about Reflecting Societal Values to Drug Prices; They Don’t Know How
March 22, 2019
-
BUSINESS Biogen/Eisai’s Aducanumab Fails, Dashing Hopes in Alzheimer’s Field
March 22, 2019
-
BUSINESS Gilead Set to Duplicate Biktarvy Success in Japan with New Stand-Alone HIV Sales Force
March 20, 2019
-
BUSINESS Employee Sues Bayer Japan for Emotional Distress over Xarelto Scandal
March 19, 2019
-
ORGANIZATION Kenporen Director Kono: Apply CEA to Reimbursement Decisions Once Credible System Established
March 18, 2019
-
BUSINESS Drug Makers, Wholesalers Establishing Supervisory Divisions as Detailing Guidelines Rollout Nears
March 15, 2019
-
REGULATORY MHLW to Promote Master Protocol Trials to Boost Efficiency in New Drug Development
March 14, 2019
-
BUSINESS Fujifilm Going Full Throttle in CDMO Biz with Buyout of Biogen Unit
March 13, 2019
-
REGULATORY Detailing Guidelines Casting Clouds over Drug Maker-Sponsored Press Seminars?
March 12, 2019
-
BUSINESS Meiji Pharma Pursuing Low-Cost Strategy to Weather Storm in Generics Space, Overseas Plants Hold Key
March 11, 2019
-
BUSINESS Eisai CEO Says “20% ROE in 2025” within Reach If All 3 Alzheimer’s Candidates, Lenvima Deliver
March 8, 2019
-
INTERVIEW JMA Exec Matsumoto: CEA Scheme Merely a Supplemental Tool to Drug Pricing System, Continued Discussions Necessary
March 7, 2019
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
